A 32-year-old Indian male presents with a 4-week history of high-grade fever (39.2°C), morbilliform rash with characteristic facial edema, and generalized lymphadenopathy. He started carbamazepine 8 weeks ago for newly diagnosed epilepsy. Laboratory investigations show WBC 12,000/mm³ with eosinophilia (2200/mm³), atypical lymphocytes, and elevated transaminases (AST 240 U/L, ALT 280 U/L). RegiSCAR criteria are met with 6 points. The clinical diagnosis of DRESS syndrome is confirmed. Which of the following represents the MOST APPROPRIATE IMMEDIATE MANAGEMENT as indicated by the structure marked **A** in the diagram?
A. Start empirical broad-spectrum antibiotics as first-line therapy while awaiting culture reports
B. Continue carbamazepine with addition of antihistamines and topical corticosteroids to manage the rash
C. Discontinue carbamazepine immediately and initiate prednisolone 1 mg/kg/day with close monitoring for organ involvement including weekly LFTs and cardiac assessment
D. Apply topical corticosteroids alone without systemic therapy and observe for spontaneous resolution
Explanation
Why option 1 is correct
DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) is a potentially life-threatening SCAR with 5–10% mortality that requires immediate and aggressive management. The structure marked A in the diagram explicitly denotes the gold-standard management: immediate discontinuation of the offending drug (carbamazepine) combined with systemic corticosteroids at prednisolone 1 mg/kg/day and vigilant monitoring for organ involvement (hepatitis, myocarditis, interstitial nephritis, autoimmune thyroiditis). The delayed onset (2–8 weeks) and herpesvirus reactivation (HHV-6 in 60–80%) explain the protracted, relapsing course; slow corticosteroid taper over 3–6 months is essential to prevent relapses. This patient meets RegiSCAR criteria and has evidence of hepatic involvement (transaminitis), making systemic corticosteroids non-negotiable. Weekly LFTs, renal function, and cardiac assessment (ECG/echocardiography) are mandatory given the 5% risk of myocarditis and 60–80% risk of hepatitis progression. [Kardaun SH et al. Br J Dermatol 2013 (RegiSCAR); Bolognia 4th ed]
Why each distractor is wrong
Option 2 (Continue carbamazepine with antihistamines and topical steroids): Continuing the offending drug in DRESS syndrome is contraindicated and dangerous. Antihistamines and topical corticosteroids alone are grossly insufficient for a systemic, life-threatening reaction with hepatitis and eosinophilia. This approach ignores the pathogenic role of the drug and the need for systemic immunosuppression.
Option 3 (Empirical broad-spectrum antibiotics as first-line): DRESS syndrome is NOT a bacterial infection; it is a drug hypersensitivity reaction with herpesvirus reactivation. Empirical antibiotics are explicitly contraindicated in management guidelines and may worsen outcomes or trigger cross-reactivity. Antibiotics are reserved only for documented secondary bacterial superinfection of skin lesions.
Option 4 (Topical corticosteroids alone without systemic therapy): Topical corticosteroids are insufficient for DRESS syndrome, which involves systemic inflammation, hepatitis, eosinophilia, and potential myocarditis. This approach would result in disease progression, organ failure, and potentially death. Systemic corticosteroids are the cornerstone of therapy.
